Legal Representation
Attorney
Jared Barrett
USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 8, 2021 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 8, 2021 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 23, 2020 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jul 21, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 17, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 17, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 17, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 4, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 10, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 10, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 20, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 1, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 28, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 25, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 23, 2019 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Oct 23, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 23, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 29, 2019 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Apr 29, 2019 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Apr 29, 2019 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Apr 26, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 21, 2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Mar 9, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 19, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development of pharmaceuticals for the treatment of rare diseases; research and development for the treatment of hypertension, kidney stones, gallstones, cholesterol, rage disorders, lactation, schizophrenia, autism, kidney disease, neurodegeneration, infantile spasms, nephrotic syndrome, muscular dystrophy, and diabetic nephropathy
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a white pathway through a center of a circle, the pathway dividing individual triangles in varying shades of blue on the left side of the pathway and varying shades of blue and green on the right side of the pathway, to the left of the word "RETROPHIN" in black.
Color Claim
The color(s) blue, green, white and black is/are claimed as a feature of the mark.
Classification
International Classes
042